comprehensive -WSS

comprehensive

author：hotspot 2025-09-05 13:30:38 - browse：4529

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

knowledge

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Kenai launches with $82 million for Parkinson’s stem cell therapy

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Kenai launches with $82 million for Parkinson’s stem cell therapy

focus

comprehensive

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

RSV vaccines may be linked to small increased risk of developing GBS

In Memoriam: Notable people who died in 2023

Former Georgia lieutenant governor says he received grand jury subpoena

BioMarin wins approval for gene therapy to treat hemophilia A

RSV vaccines may be linked to small increased risk of developing GBS

Trump demands the U.S. pay no more for drugs than other countries … again

AstraZeneca loses challenge to Medicare drug price negotiation

Activists slam private health insurers over coverage restrictions

FTX founder Sam Bankman

explore

‘The Bear’ and hospitality in hospitals

FDA does about

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Pfizer highlights cancer drugs it thinks could reignite investor interest

Hospitals use virtual reality to design more inclusive rooms for kids

Judge rejects Trump's counterclaim against E. Jean Carroll

knowledge

explore

knowledge

hotspot